PLS was high risk in early 2017 when waiting for Native title approvals and naysayers claiming we had water issues. PLS will continue to reduce costs and keep moving to becoming a low cost producer ,with likely a large injection of funds just ahead. I wouldnt call this baby high risk
- Forums
- ASX - By Stock
- PLS
- Day to day discussions on S/P
Day to day discussions on S/P, page-11517
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.16 |
Change
-0.030(0.94%) |
Mkt cap ! $9.516B |
Open | High | Low | Value | Volume |
$3.17 | $3.19 | $3.06 | $50.14M | 15.97M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 49357 | $3.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.17 | 74794 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 3.100 |
1 | 2500 | 3.090 |
2 | 510 | 3.080 |
9 | 71282 | 3.060 |
7 | 39565 | 3.050 |
Price($) | Vol. | No. |
---|---|---|
3.170 | 72164 | 4 |
3.180 | 45100 | 3 |
3.190 | 120976 | 12 |
3.200 | 51735 | 16 |
3.210 | 31725 | 9 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online